The predominant role of 18F-FDG PET/CT over MDCT in assessment of ovarian cancer patient

Objectives: This article discusses that FDG PET/CT is superior to MDCT in evaluation of ovarian cancer oncological evaluation. Patients and methods: 87 PET/CT scans of 64 women with clinically suspected or pathologically proven ovarian cancer were retrospectively analyzed. The findings of contrast e...

Full description

Bibliographic Details
Main Authors: Hemat A. Mahmoud, Haisam Atta, Waleed A. Diab, Lamiaa M. Eloteify, Hisham Imam, Adel Gabr, Mohamed A. Mekkawy, Waleed M. Omar
Format: Article
Language:English
Published: SpringerOpen 2015-12-01
Series:The Egyptian Journal of Radiology and Nuclear Medicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0378603X15001771
_version_ 1818229178463420416
author Hemat A. Mahmoud
Haisam Atta
Waleed A. Diab
Lamiaa M. Eloteify
Hisham Imam
Adel Gabr
Mohamed A. Mekkawy
Waleed M. Omar
author_facet Hemat A. Mahmoud
Haisam Atta
Waleed A. Diab
Lamiaa M. Eloteify
Hisham Imam
Adel Gabr
Mohamed A. Mekkawy
Waleed M. Omar
author_sort Hemat A. Mahmoud
collection DOAJ
description Objectives: This article discusses that FDG PET/CT is superior to MDCT in evaluation of ovarian cancer oncological evaluation. Patients and methods: 87 PET/CT scans of 64 women with clinically suspected or pathologically proven ovarian cancer were retrospectively analyzed. The findings of contrast enhanced MDCT (CE-CT) were interpreted by two experienced radiologists unaware of PET/CT findings. At least two experienced nuclear medicine physicians who were unaware of CE-MDCT findings examined PET images, evaluating localization and characterization and comparing them to co-registered PET/CT images. Diagnostic accuracy was determined on a patient level and a region level. Results: PET has significantly higher Sensitivity, specificity, PPV, NPV, and overall accuracy of 94.7%, 86.7%, 93.1%, 89.7%, and 91.9% respectively compared to 89.5%, 30%, 70.8%, 60% and 68.9% for MDCT on patient level. The diagnostic performance of PET was also better at most anatomical sites when results were analyzed on region level. Conclusions and recommendations: FDG PET in addition to conventional imaging modalities should represent an important step in the diagnostic flowchart of ovarian cancer patients for evaluating abdominal and extra-abdominal probable metastatic deposits.
first_indexed 2024-12-12T10:14:28Z
format Article
id doaj.art-5da2e40536a941819d23c01feafbf66f
institution Directory Open Access Journal
issn 0378-603X
language English
last_indexed 2024-12-12T10:14:28Z
publishDate 2015-12-01
publisher SpringerOpen
record_format Article
series The Egyptian Journal of Radiology and Nuclear Medicine
spelling doaj.art-5da2e40536a941819d23c01feafbf66f2022-12-22T00:27:42ZengSpringerOpenThe Egyptian Journal of Radiology and Nuclear Medicine0378-603X2015-12-014641313132210.1016/j.ejrnm.2015.07.011The predominant role of 18F-FDG PET/CT over MDCT in assessment of ovarian cancer patientHemat A. Mahmoud0Haisam Atta1Waleed A. Diab2Lamiaa M. Eloteify3Hisham Imam4Adel Gabr5Mohamed A. Mekkawy6Waleed M. Omar7Department of Clinical Oncology and Nuclear Medicine, Assiut University Hospital, EgyptDepartment of Radiology, South Egypt Cancer Institute, Assiut University, EgyptDepartment of Clinical Oncology and Nuclear Medicine, Assiut University Hospital, EgyptDepartment of Clinical Oncology and Nuclear Medicine, Assiut University Hospital, EgyptDepartment of Radiology, Assiut University Hospital, EgyptDepartment of Medical Oncology, South Egypt Cancer Institute, Assiut University, EgyptDepartment of Clinical Oncology and Nuclear Medicine, Assiut University Hospital, EgyptDepartment of Nuclear Medicine, National Cancer Institute, Cairo University, EgyptObjectives: This article discusses that FDG PET/CT is superior to MDCT in evaluation of ovarian cancer oncological evaluation. Patients and methods: 87 PET/CT scans of 64 women with clinically suspected or pathologically proven ovarian cancer were retrospectively analyzed. The findings of contrast enhanced MDCT (CE-CT) were interpreted by two experienced radiologists unaware of PET/CT findings. At least two experienced nuclear medicine physicians who were unaware of CE-MDCT findings examined PET images, evaluating localization and characterization and comparing them to co-registered PET/CT images. Diagnostic accuracy was determined on a patient level and a region level. Results: PET has significantly higher Sensitivity, specificity, PPV, NPV, and overall accuracy of 94.7%, 86.7%, 93.1%, 89.7%, and 91.9% respectively compared to 89.5%, 30%, 70.8%, 60% and 68.9% for MDCT on patient level. The diagnostic performance of PET was also better at most anatomical sites when results were analyzed on region level. Conclusions and recommendations: FDG PET in addition to conventional imaging modalities should represent an important step in the diagnostic flowchart of ovarian cancer patients for evaluating abdominal and extra-abdominal probable metastatic deposits.http://www.sciencedirect.com/science/article/pii/S0378603X15001771FDG PET/CTMDCTOvarian cancer
spellingShingle Hemat A. Mahmoud
Haisam Atta
Waleed A. Diab
Lamiaa M. Eloteify
Hisham Imam
Adel Gabr
Mohamed A. Mekkawy
Waleed M. Omar
The predominant role of 18F-FDG PET/CT over MDCT in assessment of ovarian cancer patient
The Egyptian Journal of Radiology and Nuclear Medicine
FDG PET/CT
MDCT
Ovarian cancer
title The predominant role of 18F-FDG PET/CT over MDCT in assessment of ovarian cancer patient
title_full The predominant role of 18F-FDG PET/CT over MDCT in assessment of ovarian cancer patient
title_fullStr The predominant role of 18F-FDG PET/CT over MDCT in assessment of ovarian cancer patient
title_full_unstemmed The predominant role of 18F-FDG PET/CT over MDCT in assessment of ovarian cancer patient
title_short The predominant role of 18F-FDG PET/CT over MDCT in assessment of ovarian cancer patient
title_sort predominant role of 18f fdg pet ct over mdct in assessment of ovarian cancer patient
topic FDG PET/CT
MDCT
Ovarian cancer
url http://www.sciencedirect.com/science/article/pii/S0378603X15001771
work_keys_str_mv AT hematamahmoud thepredominantroleof18ffdgpetctovermdctinassessmentofovariancancerpatient
AT haisamatta thepredominantroleof18ffdgpetctovermdctinassessmentofovariancancerpatient
AT waleedadiab thepredominantroleof18ffdgpetctovermdctinassessmentofovariancancerpatient
AT lamiaameloteify thepredominantroleof18ffdgpetctovermdctinassessmentofovariancancerpatient
AT hishamimam thepredominantroleof18ffdgpetctovermdctinassessmentofovariancancerpatient
AT adelgabr thepredominantroleof18ffdgpetctovermdctinassessmentofovariancancerpatient
AT mohamedamekkawy thepredominantroleof18ffdgpetctovermdctinassessmentofovariancancerpatient
AT waleedmomar thepredominantroleof18ffdgpetctovermdctinassessmentofovariancancerpatient
AT hematamahmoud predominantroleof18ffdgpetctovermdctinassessmentofovariancancerpatient
AT haisamatta predominantroleof18ffdgpetctovermdctinassessmentofovariancancerpatient
AT waleedadiab predominantroleof18ffdgpetctovermdctinassessmentofovariancancerpatient
AT lamiaameloteify predominantroleof18ffdgpetctovermdctinassessmentofovariancancerpatient
AT hishamimam predominantroleof18ffdgpetctovermdctinassessmentofovariancancerpatient
AT adelgabr predominantroleof18ffdgpetctovermdctinassessmentofovariancancerpatient
AT mohamedamekkawy predominantroleof18ffdgpetctovermdctinassessmentofovariancancerpatient
AT waleedmomar predominantroleof18ffdgpetctovermdctinassessmentofovariancancerpatient